Pfizer Inc. PFE -4.64% was months from proving its Covid-19 vaccine would even work when Chief Executive Albert Bourla got into a tense WebEx debate with his head of manufacturing. It was a warm day in June and Pfizer was racing to develop a radical new vaccine based on a […]
Read Time : 3 Minutes
BioNTech, Pfizer start rolling EMA approval filing for COVID-19 vaccine
BioNTech and Pfizer have started a rolling submission of their COVID-19 vaccine BNT162b2 to the European Medicines Agency (EMA). The news comes days after EMA named AstraZeneca’s AZD1222 as the first COVID-19 vaccine to start the rolling review process. The EMA uses rolling reviews to start assessing data on an […]